Experience
Abbott Laboratories
Medtronic Inc.
Finnegan won a significant victory for Guidant (now Abbott) in the U.S. District Court for the District of Delaware. After a two-week trial, the jury returned a verdict in Guidant’s favor on all counts, finding that all 12 of the asserted patent claims were valid and that all 12 of the accused Medtronic coronary stents infringed the asserted claims. The district court also held that none of the 12 accused Guidant stents infringed any of Medtronic’s four asserted patents and further dismissed Medtronic’s claims against Guidant for trade secret misappropriation and unfair competition.
Abbott Laboratories v. Medtronic Inc., 1:98-cv-00080, D. Del., Judge Robinson
Advanced Cardiovascular Systems v. Medtronic Vascular
Advanced Cardiovascular Systems
Trial victory in case involving commercial air conditioner components
York International
Cordis Corp. v. Guidant Inc. (Advanced Cardiovascular Systems Inc.)
Guidant Inc. (Advanced Cardiovascular Systems Inc.)
"Customer defendant" characterization helps Nikon avoid costly protracted litigation and trial
Nikon Corporation and Nikon Inc.
Bell Communications v. Fore Systems Inc.
Bell Communications
Coronary Stent Visualization Corp. v. Philips Electronic North America Corp.
Philips Electronic North America Corp.
L'Oreal
Abbott Laboratories’ dominance in the coronary stent market is protected
Abbott Laboratories
Välinge Innovation AB v. Halstead New England Corporation, The Home Depot Inc. et al.
Välinge Innovation AB
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.